Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jun;6(4):373-82.
doi: 10.1517/14622416.6.4.373.

Toward the 1,000 dollars human genome

Affiliations
Review

Toward the 1,000 dollars human genome

Simon T Bennett et al. Pharmacogenomics. 2005 Jun.

Abstract

Revolutionary new technologies, capable of transforming the economics of sequencing, are providing an unparalleled opportunity to analyze human genetic variation comprehensively at the whole-genome level within a realistic timeframe and at affordable costs. Current estimates suggest that it would cost somewhere in the region of 30 million US dollars to sequence an entire human genome using Sanger-based sequencing, and on one machine it would take about 60 years. Solexa is widely regarded as a company with the necessary disruptive technology to be the first to achieve the ultimate goal of the so-called 1,000 dollars human genome - the conceptual cost-point needed for routine analysis of individual genomes. Solexa's technology is based on completely novel sequencing chemistry capable of sequencing billions of individual DNA molecules simultaneously, a base at a time, to enable highly accurate, low cost analysis of an entire human genome in a single experiment. When applied over a large enough genomic region, these new approaches to resequencing will enable the simultaneous detection and typing of known, as well as unknown, polymorphisms, and will also offer information about patterns of linkage disequilibrium in the population being studied. Technological progress, leading to the advent of single-molecule-based approaches, is beginning to dramatically drive down costs and increase throughput to unprecedented levels, each being several orders of magnitude better than that which is currently available. A new sequencing paradigm based on single molecules will be faster, cheaper and more sensitive, and will permit routine analysis at the whole-genome level.

PubMed Disclaimer

Similar articles

  • Advances in sequencing technology.
    Chan EY. Chan EY. Mutat Res. 2005 Jun 3;573(1-2):13-40. doi: 10.1016/j.mrfmmm.2005.01.004. Mutat Res. 2005. PMID: 15829235 Review.
  • Solexa Ltd.
    Bennett S. Bennett S. Pharmacogenomics. 2004 Jun;5(4):433-8. doi: 10.1517/14622416.5.4.433. Pharmacogenomics. 2004. PMID: 15165179
  • Helicos BioSciences.
    Milos P. Milos P. Pharmacogenomics. 2008 Apr;9(4):477-80. doi: 10.2217/14622416.9.4.477. Pharmacogenomics. 2008. PMID: 18384261 Review.
  • Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.
    Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, Dahl F, Fernandez A, Staker B, Pant KP, Baccash J, Borcherding AP, Brownley A, Cedeno R, Chen L, Chernikoff D, Cheung A, Chirita R, Curson B, Ebert JC, Hacker CR, Hartlage R, Hauser B, Huang S, Jiang Y, Karpinchyk V, Koenig M, Kong C, Landers T, Le C, Liu J, McBride CE, Morenzoni M, Morey RE, Mutch K, Perazich H, Perry K, Peters BA, Peterson J, Pethiyagoda CL, Pothuraju K, Richter C, Rosenbaum AM, Roy S, Shafto J, Sharanhovich U, Shannon KW, Sheppy CG, Sun M, Thakuria JV, Tran A, Vu D, Zaranek AW, Wu X, Drmanac S, Oliphant AR, Banyai WC, Martin B, Ballinger DG, Church GM, Reid CA. Drmanac R, et al. Science. 2010 Jan 1;327(5961):78-81. doi: 10.1126/science.1181498. Epub 2009 Nov 5. Science. 2010. PMID: 19892942
  • How next-generation sequencing is transforming complex disease genetics.
    Kilpinen H, Barrett JC. Kilpinen H, et al. Trends Genet. 2013 Jan;29(1):23-30. doi: 10.1016/j.tig.2012.10.001. Epub 2012 Oct 25. Trends Genet. 2013. PMID: 23103023 Review.

Cited by

LinkOut - more resources